Medline (NASDAQ:MDLN) Major Shareholder Sells $172,727,085.27 in Stock

Medline (NASDAQ:MDLN) major shareholder Hellman & Friedman Capital Par sold 6,088,371 shares of the company’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $28.37, for a total value of $172,727,085.27. Following the completion of the transaction, the insider owned 4,806,160 shares of the company’s stock, valued at $136,350,759.20. This trade represents a 55.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Medline Stock Up 1.3%

NASDAQ MDLN opened at $42.18 on Tuesday. Medline has a one year low of $34.89 and a one year high of $43.90.

Trending Headlines about Medline

Here are the key news stories impacting Medline this week:

• Positive Sentiment: Two Mills-family directors made very large insider purchases (~2.58M shares each at $29), signaling strong insider confidence in the newly public company. Charles N. Mills filing Andrew J. Mills filing
• Positive Sentiment: Medline completed its IPO and implemented governance changes to operate as a public company — reduces transitional governance risk and may increase institutional interest. Medline Completes IPO & Governance Changes
• Positive Sentiment: Positive media attention from commentators (e.g., Jim Cramer praised the IPO), which can attract retail flows and support demand for the stock. Cramer on Medline IPO
• Neutral Sentiment: The IPO raised roughly $6.26 billion and generated a sizable Mills-family payout — important for capitalization and ownership structure but mixed for near-term free float dynamics. Chicago Business: Mills family payday
• Negative Sentiment: Major shareholder Hellman & Friedman Capital Par sold 6,088,371 shares at an average $28.37, cutting their stake by ~56% — increases available float and can pressure the stock. Hellman & Friedman filing
• Negative Sentiment: Unusual options activity: ~20,689 put contracts were bought (≈+326% vs. average), suggesting hedging or bearish positioning that may amplify short-term volatility. (Reported Dec. 22)

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.